: Computational data integration and bioactivity profiling in ToxPi. Curve-fitting of quantitative outputs from HCS applications (data acquisition, concentrationresponse assessment) in R yielded point-of-departure (POD) benchmark values, which were utilized as relative measures of toxicity. Following normalization of POD values on a 0-1 scale, values derived from sixteen distinct assays or assay parameters were integrated for quantitative bioactivity profiling in ToxPi (data visualization). In the resulting ToxPi charts, each slice is representative of an individual assay and the area of the slice is proportional to the relative bioactivity of the chemical within the dataset. ToxPi also provides a cumulative ToxPi score, a relative measure of bioactivity that can be utilized to globally rank chemicals for potential clustering. Ranking chemicals according to their overall ToxPi score can be utilized to reveal clusters of similar compounds or substances.
Figure S2:
Inter-plate replicability parameters. Assay performance between assay plates was evaluated using comparisons of normalized controls and coefficients of variation (%CV), an assay quality indicator herein defined as a single standard deviation across the mean of vehicle controls (A). Pearson (r) and Spearman (ρ) correlation analysis was used as an additional quality control to assess the assay reproducibility between plates. [CM=cardiomyocytes; HEP=hepatocytes]. Figure S3 : Intra-plate replicability parameters. The consistency of replicates in high-content screening assays was determined using linear correlation analysis (r=Pearson; ρ=Spearman) for each assay parameter. Plots depict correlations for original, non-normalized duplicate (n=2) measurements in concentration-response (n=6 concentrations for cardiomyocytes, n=5 for hepatocytes) for all 21 Concawe extracts and sixteen assay parameters. Figure S4 : Calcium-flux traces for control chemicals and two petroleum substances. Representative calcium flux-traces for cultured iPSC cardiomyocytes in the presence and absence of vehicle (1% DMSO in media), reference chemicals (tetraoctyl ammonium bromidecytotoxicity; cisapride -QT interval elongation; isoproterenol -positive chronotrope; propranolol -negative chronotrope) and two petroleum substances, CON-07 (OGO) and CON16ii (VHGO), in concentration-response are shown. Figure S5: MA plots, which demonstrate the gene expression data transformed onto the M (log ratios) and the A (mean average) scale, show the change in the average level of each transcript in the S1500+ gene set for all chemicals at all concentrations relative to the averages determined for DMSO controls. Differentially expressed genes (q<0.1), determined as described in the Materials and Methods section, are indicated by red points. *Genes that were commonly significantly differentially expressed among the cells treated with one of the five petroleum substances at the highest concentration used are shown. A total of 66 genes were significantly differentially expressed across all chemicals at the highest concentration used. *Genes that were commonly significantly differentially expressed among the cells treated with one of the five petroleum substances at the highest concentration used are shown. The top-most differentially expressed (based on log2 fold change) are shown. 
